ANIP
ANI Pharmaceuticals Inc
Price:  
66.10 
USD
Volume:  
397,542.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ANIP EV/EBITDA

-140.7%
Upside

As of 2025-07-11, the EV/EBITDA ratio of ANI Pharmaceuticals Inc (ANIP) is -52.46. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ANIP's latest enterprise value is 1,904.09 mil USD. ANIP's TTM EBITDA according to its financial statements is -36.30 mil USD. Dividing these 2 quantities gives us the above ANIP EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 9.1x - 10.0x 9.6x
Forward P/E multiples 10.4x - 10.6x 10.4x
Fair Price (37.07) - (15.66) (26.89)
Upside -156.1% - -123.7% -140.7%
66.10 USD
Stock Price
(26.89) USD
Fair Price

ANIP EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-10 -52.46
2025-07-09 -51.99
2025-07-08 -51.84
2025-07-07 -51.75
2025-07-03 -51.97
2025-07-02 -51.93
2025-07-01 -50.94
2025-06-30 -51.95
2025-06-27 -52.10
2025-06-26 -52.28
2025-06-25 -52.34
2025-06-24 -52.98
2025-06-23 -52.42
2025-06-20 -52.13
2025-06-18 -51.60
2025-06-17 -50.82
2025-06-16 -51.38
2025-06-13 -50.35
2025-06-12 -50.08
2025-06-11 -50.48
2025-06-10 -50.53
2025-06-09 -50.72
2025-06-06 -49.99
2025-06-05 -48.75
2025-06-04 -49.34
2025-06-03 -49.81
2025-06-02 -49.96
2025-05-30 -48.06
2025-05-29 -47.78
2025-05-28 -47.51
2025-05-27 -47.82
2025-05-23 -47.50
2025-05-22 -47.19
2025-05-21 -48.27
2025-05-20 -49.20
2025-05-19 -48.91
2025-05-16 -48.81
2025-05-15 -48.54
2025-05-14 -49.04
2025-05-13 -50.01
2025-05-12 -50.19
2025-05-09 -52.58
2025-05-08 -55.70
2025-05-07 -55.27
2025-05-06 -54.94
2025-05-05 -56.31
2025-05-02 -56.54
2025-05-01 -55.19
2025-04-30 -55.27
2025-04-29 -55.24